Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in England: results from the national ovarian cancer feasibility audit pilot
Sadly it is necessary when thinking about ovarian cancer, to remember how fatal the disease can be. Reduction of mortality and better outcomes are possible with modern care but this depends on optimal treatment.
This study looks at the death rates for women in the UK, diagnosed with ovarian cancer Stage 2 and above, during the period 2016-2018. The likelihood of short-term survival was compared to the probability that these women would receive standard treatment with surgery and chemo.
Overall in the UK 73% of women with ovarian cancer receive standard care. There is significant variation between different population centres with some centres in the UK providing surgical treatment for only 51% of these women.
Survival is directly related to the likelihood of adequate care. For women with ovarian cancer who had a high probability of surgery one in eight will die during the two months after diagnosis. Those women less likely to have surgery have a one in seven chance of dying during the same two months.
No comments:
Post a Comment